.png)
Precision Oncology. Powered by Genomic Intelligence.
Agilisium’s Pharmacogenomic Reporting Engine delivers actionable, variant-driven insights directly to clinicians, accelerating time-to-decision, improving safety, and enhancing treatment precision
.png)
Trusted Market Leader for Life Sciences
Analytics & AI Agents








The Challenge
Why Oncology Needs Faster, Safer, Genomics-Guided Treatment
Siloed Genomic Data
Variant data lives across fragmented, siloed genomic databases
Manual, Slow Workflows
Clinicians face time-consuming, manual interpretation workflows
Error-Prone Drug Mapping
Mapping pharmacogenomic risk factors to real drug labels is error-prone
Compliance Risks from Poor Docs
Regulatory frameworks require strict compliance, yet documentation is inconsistent
The need: a fully automated, FDA-aligned decision support layer for real-time, variant-guided oncology
Book a demoPharmacogenomic Reporting Engine
Variant-to-Therapy, Simplified by Automation
Real-time variant-to-drug insights, powered by FDA-aligned clinical automation.
Aggregates PGx Data from CPIC, CIViC, PharmGKB, and others
Maps Patient Variants to Drug Labels using a compliant engine
Flags High-Risk Prescriptions before they’re issued
Fully Automated Reporting Workflows
CPIC/FDA-Aligned Logic
Supports 500+ Gene-Drug Associations across oncology therapeutics
Commercial Impact That Matters
Boosting Reach, ROI, and Regulatory Confidence
80%+ reduction in PGx reporting cycle time
Reduced adverse drug events via high-risk prescription alerts
>35% improvement in therapeutic efficacy using genomically guided treatment
Compliant, consistent reports aligned with FDA labeling standards
Enables faster, data-driven precision medicine—without the manual burden

Who We Serve
On the journey from Molecule to Medicine, we fast-track innovation across the pharma value chain
Featured News and Insights

GET STARTED
Unleash Seamless
Data Management
Transform your Analytics Challenges into Practical Data Solutions, from Design to Deployment.